Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Deep mutational scanning reveals functional constraints and antibody-escape potential of Lassa virus glycoprotein complex

Immunity(2024)10.1016/j.immuni.2024.06.013Source: DataRank Database

Deep mutational scanning reveals functional constraints and antibody-escape potential of Lassa virus glycoprotein complex is a research paper published in Immunity (2024). On theSindex it has a DataRank of 0. It has been cited 26 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access26 citations

Download PDF

Cite:

Linked data & code

bioproject geo gen refseq uniprot pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (14 grants)Impact (FWCI 7.78)OA: hybridTopics (38)IDs (PubMed, PMC, OpenAlex)Annotations (7)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Katharine H. D. Crawford ORCID,Michael Murphy ORCID,Jared Galloway ORCID,Hugh K. Haddox ORCID,Frederick A. Matsen ORCID

Live enrichment

PubMed:39013466 PMC:PMC11390330 OpenAlex:https://openalex.org/W4400651824

NIAID

Grant: SCR_022606

NIAID

Grant: F30AI149928

NIAID

Grant: U19AI135995

NIAID

Grant: UL1TR002550

NIAID

Grant: U01AI151812

NIAID

Grant: R01AI141707

NCI NIH HHS

Grant: P30 CA015704

NIH HHS

Grant: S10 OD028685

NIH HHS

Grant: S10 OD020069

Howard Hughes Medical Institute

National Institutes of Health

GlaxoSmithKline

Fred Hutchinson Cancer Center

Pfizer

FWCI

7.78

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

hybridLicense: cc-by

journalhttp://www.cell.com/article/S1074761324003194/pdf

publisherhttp://www.cell.com/article/S1074761324003194/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1074761324003194?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1074761324003194?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.immuni.2024.06.013

Fields of Study

Viral Infections and Outbreaks ResearchVirus-based gene therapy researchSARS-CoV-2 and COVID-19 Research

MeSH Terms

AnimalsAntibodies, MonoclonalAntibodies, ViralGlycoproteinsHumansLassa FeverLassa virusMutationViral Envelope ProteinsVirus InternalizationImmune EvasionAntibodies, NeutralizingHEK293 Cells

Keywords

BiologyLassa virusVirologyAntibodyMonoclonal antibodyGlycoproteinNeutralizationVirusLassa feverNeutralizing antibodyMutationIn silicoGeneGeneticsGPCAntigenic variationDeep Mutational ScanningAntibody EscapeGlobal EpistasisArevirumabArevirumab-3Arena Virus